US Patent Issued to Amylyx Pharmaceuticals on March 11 for "Compositions of bile acids and phenylbutyrate compounds" (Canadian, American Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,027, issued on March 11, was assigned to Amylyx Pharmaceuticals Inc. (Cambridge, Mass.).

"Compositions of bile acids and phenylbutyrate compounds" was invented by Joshua Cohen (Canton, Mass.), Justin Klee (Cambridge, Mass.) and David Wai Fung Ma (Whitby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions including a phenylbutyrate compound and a bile acid, and methods of processing such compositions."

The patent was filed on Dec. 8, 2022, under Application No. 18/077,296.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...